Alpha-fetoprotein (AFP), although recognized as a reliable marker for liver cancer screening and early diagnosis, numerous studies have shown that nearly 80% of small HCC nodules do not exhibit elevated AFP levels, and its sensitivity for tumors smaller than 3 cm is less than 25%31. This evidence concerns the gene AFP and hepatocellular carcinoma.